Skip to main content
DNA Labs India

SPART Gene SPG20 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

SPART Gene SPG20 NGS Genetic Test

Short Name: SPG20 NGS Genetic Test

Also known as: SPART gene sequencing, SPG20 gene NGS test, Troyer syndrome genetic test, Hereditary Spastic Paraplegia type 20 genetic test

SPART Gene SPG20 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood / Extracted DNA / One drop blood on FTA card samples. Results in Reports are available in 3 to 4 weeks after the sample reaches the laboratory. They will be shared via patient portal, email, and WhatsApp.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the SPART Gene SPG20 NGS Genetic Test is to identify pathogenic variants in the SPG20 gene. It helps confirm or exclude SPG20 in individuals presenting with progressive neuromuscular symptoms, provides accurate recurrence risk information for families, and supports clinical management and reproductive planning.

Test Code
4525
CPT Code
N/A
ICD Code
G11.4
Price
₹20,000
Sample Type
Blood / Extracted DNA / One drop blood on FTA card
Result Time
Reports are available in 3 to 4 weeks after the sample reaches the laboratory. They will be shared via patient portal, email, and WhatsApp.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation or fasting is required. Please carry any previous neurological or imaging reports and a clinical summary. A genetic counselling session will be arranged before sample collection to document family history and draw a pedigree chart.

Method: Peripheral venous blood collection / dried blood spot / DNA submission

Step 2

Laboratory Analysis

A blood sample is collected by a trained phlebotomist into an EDTA vacutainer. Alternatively, the laboratory can accept extracted DNA or one drop of blood on an FTA card. The procedure is quick and causes minimal discomfort.

Step 3

Report Delivery

You can resume routine activities immediately. The sample will be transported to the laboratory at room temperature. Reports are shared in 3 to 4 weeks through the patient portal, email, or WhatsApp.

Timeline: Reports are available in 3 to 4 weeks after the sample reaches the laboratory. They will be shared via patient portal, email, and WhatsApp.

Patient Instructions

1
Before the Test:No fasting is needed. A pre-test genetic counselling session is recommended to record clinical history and family pedigree. Please bring any previous medical records related to neurological symptoms.
2
During the Test:A blood sample will be drawn from your arm into an EDTA tube, or an FTA card / extracted DNA sample will be accepted. The procedure is safe and quick.
3
After the Test:No restrictions. The laboratory will process the sample and share reports in 3 to 4 weeks. Your genetic counselor will help explain the results and next steps.

About This Test

Who Should Get This Test

The purpose of the SPART Gene SPG20 NGS Genetic Test is to identify pathogenic variants in the SPG20 gene. It helps confirm or exclude SPG20 in individuals presenting with progressive neuromuscular symptoms, provides accurate recurrence risk information for families, and supports clinical management and reproductive planning.

How to Prepare

  • Use an EDTA tube for whole blood collection
  • FTA card must be clearly labelled with patient details
  • Extracted DNA should be accompanied by quantity and quality information
  • No fasting is required
  • Provide clinical history and pedigree chart after genetic counselling

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"For families with a child affected by SPG20, reproductive genetic counselling and carrier testing can help clarify recurrence risk. This NGS test provides a genetic basis for diagnosis and supports informed family planning decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood / Extracted DNA / One drop blood on FTA card
Sample Volume2-3 mL whole blood in EDTA tube or one drop blood on FTA card
ContainerEDTA vacutainer / FTA card / DNA sample tube
Collection MethodPeripheral venous blood collection / dried blood spot / DNA submission

Sample Stability

Whole blood in EDTA: 2–8°C for up to 72 hours
Extracted DNA: -20°C for up to 7 days
FTA card: Room temperature for up to 4 weeks
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Quantity not sufficient for testing
  • Improperly labelled or unlabelled sample
  • Sample received without consent or counselling documentation

Understanding Your Results

This test is interpreted in the context of clinical presentation and family history. All variants are classified according to international guidelines, and the report should be reviewed by a clinical geneticist or neurologist.
📊

Biallelic pathogenic variants detected

Consistent with autosomal recessive SPG20; clinical correlation required.

📊

Single pathogenic variant detected

Indicates carrier status; carrier alone is not expected to cause SPG20.

📊

Variant of uncertain significance detected

Clinical significance is unclear; family segregation and further testing are recommended.

📊

No pathogenic variant detected

Does not exclude SPG20; other hereditary spastic paraplegia genes or alternative diagnoses should be considered.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or neurologist if you or a family member has progressive muscle stiffness, weakness, walking difficulties, speech or swallowing problems, intellectual disability, seizures, vision problems, or a family history of hereditary spastic paraplegia.

Limitations

  • This test does not detect large structural rearrangements, repeat expansions, or mitochondrial variants.
  • Variants in promoter or deep intronic regions may not be identified.
  • A negative result does not completely exclude SPG20 if clinical suspicion is very high.
  • Variant classification may change over time as new evidence emerges.

Risks & Considerations

  • Minimal discomfort or bruising at the blood collection site
  • Possibility of discovering carrier status
  • Possible psychological impact on family members
  • Inconclusive result due to variant of uncertain significance

Interfering Factors

  • Sample contamination
  • Poor DNA quality or quantity
  • Mosaicism
  • Deep intronic or regulatory variants not covered by standard NGS
  • Large deletions or duplications not detected by sequencing

Compare With Similar Tests

TestSPART Gene SPG20 NGS Genetic Test
ComparisonSPART Gene SPG20 NGS Genetic Test

Frequently Asked Questions

What is the SPART Gene SPG20 NGS Genetic Test?
It is a targeted next-generation sequencing test that analyzes the SPG20 gene for pathogenic variants. It helps diagnose SPG20, a rare inherited neurological disorder affecting the nervous system.
What condition is caused by SPG20 gene variants?
SPG20 causes a rare form of hereditary spastic paraplegia marked by progressive muscle stiffness and weakness, difficulty walking, difficulty speaking and swallowing, intellectual disability, seizures, and vision problems.
How is the SPART Gene SPG20 NGS Genetic Test performed?
The test uses a blood sample, extracted DNA, or one drop of blood on an FTA card. DNA is enriched for SPG20 coding regions and analyzed by NGS. Results are reported in 3 to 4 weeks.
Who should consider this genetic test?
People with symptoms suggestive of SPG20, such as progressive stiffness, gait difficulty, dysarthria, dysphagia, intellectual disability, seizures or vision problems, as well as family members at risk of inheriting a SPG20 variant.
Is SPG20 inherited in an autosomal recessive pattern?
Yes, SPG20 is inherited in an autosomal recessive manner. A child needs to inherit two pathogenic SPG20 variants, one from each parent, to develop SPG20. Carriers usually do not show symptoms.
Can this test be used for carrier screening?
Yes. The NGS test can detect heterozygous pathogenic variants in unaffected carriers. Carrier testing is best performed with pre-test genetic counselling and family testing.
What is the cost of the SPART Gene SPG20 NGS Genetic Test at DNA Labs India?
The test costs INR 20,000, which includes genetic testing, interpretation, counseling support, and transparent access to raw data, FASTQ, and VCF files along with the clinical report.
What is the turnaround time for this test?
Reports are usually available in 3 to 4 weeks after the sample reaches the laboratory.
What sample is needed and is fasting required?
Blood, extracted DNA, or one drop of blood on an FTA card can be used. No fasting is required. Home sample collection is available in multiple cities across India.
What do the genetic test results mean?
Results are interpreted in the context of clinical history. Detection of two pathogenic SPG20 variants confirms SPG20. A single variant indicates carrier status. Negative results do not completely exclude SPG20 if the disorder is strongly suspected.
Does DNA Labs India provide raw data with the report?
Yes, DNA Labs India provides Raw Data, FASTQ, and VCF files along with the conclusive clinical report for the SPART Gene SPG20 NGS Genetic Test.
Do I need a doctor's prescription for this test?
While you can book the test online, pre-test genetic counseling and a clinician consultation are recommended because SPG20 is a rare genetic disorder. A genetic counselor will help evaluate clinical history and family pedigree.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.